Back to Trexquant Investment LP Trexquant Investment LP

CNTA

Showing 8 of 11 quarters

Position history for Trexquant Investment LPTrexquant Investment LP's holdings in CENTESSA PHARMACEUTICALS PLC

As of its Q1 2026 13F, Trexquant Investment held 390,951 shares of CNTA (Centessa Pharmaceuticals), worth $15.5M. Trexquant Investment's 13F filings listed CNTA from Q4 2023 to Q1 2026, 10 quarterly filings. CNTA was 0.1% of Trexquant Investment's reported 13F portfolio.

Final Value

$0

Final Shares

0

Total Value Change

-$2.7M

Total Shares Change

-170,951

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Exited
0
-100.0%
$00.0%$40.50
0
2026-Q1
Increased
390,951
+166.8%
$15.5M0.1%$26.20
54
2025-Q4
Increased
146,523
+135.2%
$3.7M0.0%$24.74
43
2025-Q3
Decreased
62,310
-58.8%
$1.5M0.0%$24.40
0
2025-Q2
Decreased
151,352
-42.7%
$2M0.0%$13.13
0
2025-Q1
Increased
263,994
+1.1%
$3.8M0.0%$14.59
27
2024-Q4
Increased
261,184
+52.8%
$4.4M0.1%$16.35
37
2024-Q3
Increased
170,951
+290.8%
$2.7M0.0%$15.79
42

Other major holders of CNTA: Avoro Capital Advisors LLC, Adage Capital Partners GP, L.L.C., Pentwater Capital Management LP

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used